Research
Hormonal
Adiponectin levels increase significantly post-semaglutide add-on therapy, with the greatest increase in the obesity group (+3.70 μg/mL).
Increased adiponectin levels with semaglutide may enhance metabolic health in diabetic patients.
StrongSupportsmedium confidence
Adiponectin levels increased significantly post-semaglutide add-on therapy (p < 0.05).
Why this rating
The study design supports the reliability of the findings.
Source
Effect of Semaglutide Add-on to Metformin on Visceral Adiposity Index and Markers of Visceral Adipose Tissue Activity in Type 2 Diabetic Patients
Abid Shaheer et al. · Biomedical & Pharmacology Journal · 2025
other · n=90Cited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →